
@article{takeuchi2013,
	title = {Effects of Risperidone and Olanzapine Dose Reduction on Cognitive Function in Stable Patients With Schizophrenia: An Open-Label, Randomized, Controlled, Pilot Study},
	author = {Takeuchi, H. and Suzuki, T. and Remington, G. and Bies, R. R. and Abe, T. and Graff-Guerrero, A. and Watanabe, K. and Mimura, M. and Uchida, H.},
	year = {2013},
	month = {07},
	date = {2013-07-01},
	journal = {Schizophrenia Bulletin},
	pages = {993--998},
	volume = {39},
	number = {5},
	doi = {10.1093/schbul/sbt090},
	url = {http://dx.doi.org/10.1093/schbul/sbt090},
	langid = {en}
}

@article{élie2009,
	title = {Cognitive effects of antipsychotic dosage and polypharmacy: a study with the BACS in patients with schizophrenia and schizoaffective disorder},
	author = {{Élie}, D. and Poirier, M. and Chianetta, JM and Durand, M. and {Grégoire}, CA and Grignon, S.},
	year = {2009},
	month = {01},
	date = {2009-01-22},
	journal = {Journal of Psychopharmacology},
	pages = {1037--1044},
	volume = {24},
	number = {7},
	doi = {10.1177/0269881108100777},
	url = {http://dx.doi.org/10.1177/0269881108100777},
	langid = {en}
}

@article{joshi2021,
	title = {Anticholinergic Medication Burden{\textendash}Associated Cognitive Impairment in Schizophrenia},
	author = {Joshi, Yash B. and Thomas, Michael L. and Braff, David L. and Green, Michael F. and Gur, Ruben C. and Gur, Raquel E. and Nuechterlein, Keith H. and Stone, William S. and Greenwood, Tiffany A. and Lazzeroni, Laura C. and MacDonald, Laura R. and Molina, Juan L. and Nungaray, John A. and Radant, Allen D. and Silverman, Jeremy M. and Sprock, Joyce and Sugar, Catherine A. and Tsuang, Debby W. and Tsuang, Ming T. and Turetsky, Bruce I. and Swerdlow, Neal R. and Light, Gregory A.},
	year = {2021},
	month = {09},
	date = {2021-09-01},
	journal = {American Journal of Psychiatry},
	pages = {838--847},
	volume = {178},
	number = {9},
	doi = {10.1176/appi.ajp.2020.20081212},
	url = {http://dx.doi.org/10.1176/appi.ajp.2020.20081212},
	langid = {en}
}

@article{honey1999,
	title = {Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia},
	author = {Honey, Garry D. and Bullmore, Edward T. and Soni, William and Varatheesan, Malini and Williams, Steve C. R. and Sharma, Tonmoy},
	year = {1999},
	month = {11},
	date = {1999-11-09},
	journal = {Proceedings of the National Academy of Sciences},
	pages = {13432--13437},
	volume = {96},
	number = {23},
	doi = {10.1073/pnas.96.23.13432},
	url = {http://dx.doi.org/10.1073/pnas.96.23.13432},
	langid = {en}
}

@article{mishara2004,
	title = {A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book},
	author = {Mishara, Aaron L and Goldberg, Terry E},
	year = {2004},
	month = {05},
	date = {2004-05},
	journal = {Biological Psychiatry},
	pages = {1013--1022},
	volume = {55},
	number = {10},
	doi = {10.1016/j.biopsych.2004.01.027},
	url = {http://dx.doi.org/10.1016/j.biopsych.2004.01.027},
	langid = {en}
}

@article{husa2017,
	title = {Lifetime antipsychotic medication and cognitive performance in schizophrenia at age 43 years in a general population birth cohort},
	author = {Husa, Anja P. and Moilanen, Jani and Murray, Graham K. and Marttila, Riikka and Haapea, Marianne and Rannikko, Irina and Barnett, Jennifer H. and Jones, Peter B. and Isohanni, Matti and Remes, Anne M. and Koponen, Hannu and Miettunen, Jouko and {Jääskeläinen}, Erika},
	year = {2017},
	month = {01},
	date = {2017-01},
	journal = {Psychiatry Research},
	pages = {130--138},
	volume = {247},
	doi = {10.1016/j.psychres.2016.10.085},
	url = {http://dx.doi.org/10.1016/j.psychres.2016.10.085},
	langid = {en}
}

@article{woodward2005,
	title = {A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia},
	author = {Woodward, Neil D. and Purdon, Scot E. and Meltzer, Herbert Y. and Zald, David H.},
	year = {2005},
	month = {03},
	date = {2005-03-23},
	journal = {The International Journal of Neuropsychopharmacology},
	pages = {457--472},
	volume = {8},
	number = {3},
	doi = {10.1017/s146114570500516x},
	url = {http://dx.doi.org/10.1017/S146114570500516X},
	langid = {en}
}

@article{moritz2013,
	title = {Assessment of subjective cognitive and emotional effects of antipsychotic drugs. Effect by defect?},
	author = {Moritz, Steffen and Andreou, Christina and Klingberg, Stefan and Thoering, Teresa and Peters, Maarten J.V.},
	year = {2013},
	month = {09},
	date = {2013-09},
	journal = {Neuropharmacology},
	pages = {179--186},
	volume = {72},
	doi = {10.1016/j.neuropharm.2013.04.039},
	url = {http://dx.doi.org/10.1016/j.neuropharm.2013.04.039},
	langid = {en}
}

@article{arnsten1995,
	title = {Dopamine D2 receptor mechanisms contribute to age-related cognitive decline: the effects of quinpirole on memory and motor performance in monkeys},
	author = {Arnsten, AF and Cai, JX and Steere, JC and Goldman-Rakic, PS},
	year = {1995},
	month = {05},
	date = {1995-05-01},
	journal = {The Journal of Neuroscience},
	pages = {3429--3439},
	volume = {15},
	number = {5},
	doi = {10.1523/jneurosci.15-05-03429.1995},
	url = {http://dx.doi.org/10.1523/JNEUROSCI.15-05-03429.1995},
	langid = {en}
}

@article{ramaekers1999,
	title = {Psychomotor, Cognitive, Extrapyramidal, and Affective Functions of Healthy Volunteers During Treatment With an Atypical (Amisulpride) and a Classic (Haloperidol) Antipsychotic},
	author = {Ramaekers, J. G. and Louwerens, J. W. and Muntjewerff, N. D. and Milius, H. and de Bie, A. and Rosenzweig, P. and Patat, A. and {O'Hanlon}, J. F.},
	year = {1999},
	month = {06},
	date = {1999-06},
	journal = {Journal of Clinical Psychopharmacology},
	pages = {209--221},
	volume = {19},
	number = {3},
	doi = {10.1097/00004714-199906000-00003},
	url = {http://dx.doi.org/10.1097/00004714-199906000-00003},
	langid = {en}
}

@article{Kapur2001,
	title = {Does Fast Dissociation From the Dopamine D{\textsubscript{2}}Receptor Explain the Action of Atypical Antipsychotics?: A New Hypothesis},
	author = {Kapur, Shitij and Seeman, Philip},
	year = {2001},
	month = {03},
	date = {2001-03},
	journal = {American Journal of Psychiatry},
	pages = {360--369},
	volume = {158},
	number = {3},
	doi = {10.1176/appi.ajp.158.3.360},
	url = {http://dx.doi.org/10.1176/appi.ajp.158.3.360},
	langid = {en}
}

@article{bilder2002,
	title = {Neurocognitive Effects of Clozapine, Olanzapine, Risperidone, and Haloperidol in Patients With Chronic Schizophrenia or Schizoaffective Disorder},
	author = {Bilder, Robert M. and Goldman, Robert S. and Volavka, Jan and Czobor, Pal and Hoptman, Matthew and Sheitman, Brian and Lindenmayer, Jean-Pierre and Citrome, Leslie and McEvoy, Joseph and Kunz, Michal and Chakos, Miranda and Cooper, Thomas B. and Horowitz, Terri L. and Lieberman, Jeffrey A.},
	year = {2002},
	month = {06},
	date = {2002-06},
	journal = {American Journal of Psychiatry},
	pages = {1018--1028},
	volume = {159},
	number = {6},
	doi = {10.1176/appi.ajp.159.6.1018},
	url = {http://dx.doi.org/10.1176/appi.ajp.159.6.1018},
	langid = {en}
}

@article{meltzer1999,
	title = {The Effects of Clozapine, Risperidone, and Olanzapine on Cognitive Function in Schizophrenia},
	author = {Meltzer, H. Y. and McGurk, S. R.},
	year = {1999},
	month = {01},
	date = {1999-01-01},
	journal = {Schizophrenia Bulletin},
	pages = {233--256},
	volume = {25},
	number = {2},
	doi = {10.1093/oxfordjournals.schbul.a033376},
	url = {http://dx.doi.org/10.1093/oxfordjournals.schbul.a033376},
	langid = {en}
}

@article{keefe2006,
	title = {Long-Term Neurocognitive Effects of Olanzapine or Low-Dose Haloperidol in First-Episode Psychosis},
	author = {Keefe, Richard S.E. and Seidman, Larry J. and Christensen, Bruce K. and Hamer, Robert M. and Sharma, Tonmoy and Sitskoorn, Margriet M. and Rock, Stephanie L. and Woolson, Sandra and Tohen, Mauricio and Tollefson, Gary D. and Sanger, Todd M. and Lieberman, Jeffrey A.},
	year = {2006},
	month = {01},
	date = {2006-01},
	journal = {Biological Psychiatry},
	pages = {97--105},
	volume = {59},
	number = {2},
	doi = {10.1016/j.biopsych.2005.06.022},
	url = {http://dx.doi.org/10.1016/j.biopsych.2005.06.022},
	langid = {en}
}

@article{harvey2005,
	title = {Treatment of Cognitive Impairment in Early Psychosis: A Comparison of Risperidone and Haloperidol in a Large Long-Term Trial},
	author = {Harvey, Philip D. and Rabinowitz, Jonathan and Eerdekens, Marielle and Davidson, Michael},
	year = {2005},
	month = {10},
	date = {2005-10},
	journal = {American Journal of Psychiatry},
	pages = {1888--1895},
	volume = {162},
	number = {10},
	doi = {10.1176/appi.ajp.162.10.1888},
	url = {http://dx.doi.org/10.1176/appi.ajp.162.10.1888},
	langid = {en}
}

@article{meltzer2008,
	title = {Does stimulation of 5-HT1A receptors improve cognition in schizophrenia?},
	author = {Meltzer, Herbert Y. and Sumiyoshi, Tomiki},
	year = {2008},
	month = {12},
	date = {2008-12},
	journal = {Behavioural Brain Research},
	pages = {98--102},
	volume = {195},
	number = {1},
	doi = {10.1016/j.bbr.2008.05.016},
	url = {http://dx.doi.org/10.1016/j.bbr.2008.05.016},
	langid = {en}
}

@article{désaméricq2013,
	title = {Long-term neurocognitive effects of antipsychotics in schizophrenia: a network meta-analysis},
	author = {{Désaméricq}, G. and Schurhoff, F. and Meary, A. and {Szöke}, A. and Macquin-Mavier, I. and {Bachoud-Lévi}, A. C. and Maison, P.},
	year = {2013},
	month = {10},
	date = {2013-10-22},
	journal = {European Journal of Clinical Pharmacology},
	pages = {127--134},
	volume = {70},
	number = {2},
	doi = {10.1007/s00228-013-1600-y},
	url = {http://dx.doi.org/10.1007/s00228-013-1600-y},
	langid = {en}
}

@article{nielsen2015,
	title = {Second-generation antipsychotic effect on cognition in patients with schizophrenia-a meta-analysis of randomized clinical trials},
	author = {Nielsen, R. E. and Levander, S. and {Kjaersdam Telléus}, G. and Jensen, S. O. W. and {Østergaard Christensen}, T. and Leucht, S.},
	year = {2015},
	month = {01},
	date = {2015-01-16},
	journal = {Acta Psychiatrica Scandinavica},
	pages = {185--196},
	volume = {131},
	number = {3},
	doi = {10.1111/acps.12374},
	url = {http://dx.doi.org/10.1111/acps.12374},
	langid = {en}
}

@article{keefe2007,
	title = {Neurocognitive Effects of Antipsychotic Medications in Patients With Chronic Schizophrenia in the CATIE Trial},
	author = {Keefe, Richard S. E.},
	year = {2007},
	month = {06},
	date = {2007-06-01},
	journal = {Archives of General Psychiatry},
	pages = {633},
	volume = {64},
	number = {6},
	doi = {10.1001/archpsyc.64.6.633},
	url = {http://dx.doi.org/10.1001/archpsyc.64.6.633},
	langid = {en}
}

@article{barnett2007,
	title = {Improvement and decline of cognitive function in schizophrenia over one year: a longitudinal investigation using latent growth modelling},
	author = {Barnett, Jennifer H and Croudace, Tim J and Jaycock, Sue and Blackwell, Candice and Hynes, Fiona and Sahakian, Barbara J and Joyce, Eileen M and Jones, Peter B},
	year = {2007},
	month = {05},
	date = {2007-05-09},
	journal = {BMC Psychiatry},
	volume = {7},
	number = {1},
	doi = {10.1186/1471-244x-7-16},
	url = {http://dx.doi.org/10.1186/1471-244X-7-16},
	langid = {en}
}

@article{leucht2008,
	title = {How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials},
	author = {Leucht, S and Arbter, D and Engel, R R and Kissling, W and Davis, J M},
	year = {2008},
	month = {01},
	date = {2008-01-08},
	journal = {Molecular Psychiatry},
	pages = {429--447},
	volume = {14},
	number = {4},
	doi = {10.1038/sj.mp.4002136},
	url = {http://dx.doi.org/10.1038/sj.mp.4002136},
	langid = {en}
}

@article{tandon2007,
	title = {First- and Second-Generation Antipsychotics: Learning From CUtLASS and CATIE},
	author = {Tandon, Rajiv and Carpenter, William T. and Davis, John M.},
	year = {2007},
	month = {08},
	date = {2007-08-01},
	journal = {Archives of General Psychiatry},
	pages = {977},
	volume = {64},
	number = {8},
	doi = {10.1001/archpsyc.64.8.977},
	url = {http://dx.doi.org/10.1001/archpsyc.64.8.977},
	langid = {en}
}

@article{takeuchi2017,
	title = {Neurocognitive Benefits of Second-Generation Antipsychotics Versus Placebo},
	author = {Takeuchi, Hiroyoshi and Thiyanavadivel, Sadhana and Fervaha, Gagan and Remington, Gary},
	year = {2017},
	month = {04},
	date = {2017-04},
	journal = {Journal of Clinical Psychopharmacology},
	pages = {274--276},
	volume = {37},
	number = {2},
	doi = {10.1097/jcp.0000000000000662},
	url = {http://dx.doi.org/10.1097/JCP.0000000000000662},
	langid = {en}
}

@article{zanelli2019,
	title = {Cognitive Change in Schizophrenia and Other Psychoses in the Decade Following the First Episode},
	author = {Zanelli, Jolanta and Mollon, Josephine and Sandin, Sven and Morgan, Craig and Dazzan, Paola and Pilecka, Izabela and Reis Marques, Tiago and David, Anthony S. and Morgan, Kevin and Fearon, Paul and Doody, Gillian A. and Jones, Peter B. and Murray, Robin M. and Reichenberg, Abraham},
	year = {2019},
	month = {10},
	date = {2019-10-01},
	journal = {American Journal of Psychiatry},
	pages = {811--819},
	volume = {176},
	number = {10},
	doi = {10.1176/appi.ajp.2019.18091088},
	url = {http://dx.doi.org/10.1176/appi.ajp.2019.18091088},
	langid = {en}
}

@article{keefe2014,
	title = {The Longitudinal Course of Cognitive Impairment in Schizophrenia},
	author = {Keefe, Richard S. E.},
	year = {2014},
	month = {05},
	date = {2014-05},
	journal = {The Journal of Clinical Psychiatry},
	pages = {8--13},
	volume = {75},
	number = {suppl 2},
	doi = {10.4088/jcp.13065su1.02},
	url = {http://dx.doi.org/10.4088/JCP.13065su1.02}
}

@article{trampush2015,
	title = {Relationship of Cognition to Clinical Response in First-Episode Schizophrenia Spectrum Disorders},
	author = {Trampush, Joey W. and Lencz, Todd and DeRosse, Pamela and John, Majnu and Gallego, Juan A. and Petrides, Georgios and Hassoun, Youssef and Zhang, Jian-Ping and Addington, Jean and Kellner, Charles H. and Tohen, Mauricio and Burdick, Katherine E. and Goldberg, Terry E. and Kane, John M. and Robinson, Delbert G. and Malhotra, Anil K.},
	year = {2015},
	month = {09},
	date = {2015-09-25},
	journal = {Schizophrenia Bulletin},
	pages = {1237--1247},
	volume = {41},
	number = {6},
	doi = {10.1093/schbul/sbv120},
	url = {http://dx.doi.org/10.1093/schbul/sbv120},
	langid = {en}
}

@article{gold1999,
	title = {Longitudinal Study of Cognitive Function in First-Episode and Recent-Onset Schizophrenia},
	author = {Gold, Sherri and Arndt, Stephan and Nopoulos, Peg and {O{\textquoteright}Leary}, Daniel S. and Andreasen, Nancy C.},
	year = {1999},
	month = {09},
	date = {1999-09-01},
	journal = {American Journal of Psychiatry},
	pages = {1342--1348},
	volume = {156},
	number = {9},
	doi = {10.1176/ajp.156.9.1342},
	url = {http://dx.doi.org/10.1176/ajp.156.9.1342},
	langid = {en}
}

@article{goldberg2007,
	title = {Cognitive Improvement After Treatment With Second-Generation Antipsychotic Medications in First-Episode Schizophrenia},
	author = {Goldberg, Terry E. and Goldman, Robert S. and Burdick, Katherine E. and Malhotra, Anil K. and Lencz, Todd and Patel, Raman C. and Woerner, Margaret G. and Schooler, Nina R. and Kane, John M. and Robinson, Delbert G.},
	year = {2007},
	month = {10},
	date = {2007-10-01},
	journal = {Archives of General Psychiatry},
	pages = {1115},
	volume = {64},
	number = {10},
	doi = {10.1001/archpsyc.64.10.1115},
	url = {http://dx.doi.org/10.1001/archpsyc.64.10.1115},
	langid = {en}
}

@article{omachi2018,
	title = {Dose Reduction/Discontinuation of Antipsychotic Drugs in Psychosis; Effect on Cognition and Functional Outcomes},
	author = {Omachi, Yoshie and Sumiyoshi, Tomiki},
	year = {2018},
	month = {09},
	date = {2018-09-20},
	journal = {Frontiers in Psychiatry},
	volume = {9},
	doi = {10.3389/fpsyt.2018.00447},
	url = {http://dx.doi.org/10.3389/fpsyt.2018.00447}
}

@article{Barak2007,
	title = {Scopolamine Induces Disruption of Latent Inhibition which is Prevented by Antipsychotic Drugs and an Acetylcholinesterase Inhibitor},
	author = {Barak, Segev and Weiner, Ina},
	year = {2006},
	month = {09},
	date = {2006-09-13},
	journal = {Neuropsychopharmacology},
	pages = {989--999},
	volume = {32},
	number = {5},
	doi = {10.1038/sj.npp.1301208},
	url = {http://dx.doi.org/10.1038/sj.npp.1301208},
	langid = {en}
}

@article{egberts2021,
	title = {Anticholinergic Drug Burden and Delirium: A Systematic Review},
	author = {Egberts, Angelique and Moreno-Gonzalez, Rafael and Alan, Hava and Ziere, Gijsbertus and Mattace-Raso, Francesco U.S.},
	year = {2021},
	month = {01},
	date = {2021-01},
	journal = {Journal of the American Medical Directors Association},
	pages = {65--73.e4},
	volume = {22},
	number = {1},
	doi = {10.1016/j.jamda.2020.04.019},
	url = {http://dx.doi.org/10.1016/j.jamda.2020.04.019},
	langid = {en}
}

@article{coupland2019,
	title = {Anticholinergic Drug Exposure and the Risk of Dementia},
	author = {Coupland, Carol A. C. and Hill, Trevor and Dening, Tom and Morriss, Richard and Moore, Michael and Hippisley-Cox, Julia},
	year = {2019},
	month = {08},
	date = {2019-08-01},
	journal = {JAMA Internal Medicine},
	pages = {1084},
	volume = {179},
	number = {8},
	doi = {10.1001/jamainternmed.2019.0677},
	url = {http://dx.doi.org/10.1001/jamainternmed.2019.0677},
	langid = {en}
}

@article{joung2019,
	title = {Association of Anticholinergic Use with Incidence of Alzheimer{\textquoteright}s Disease: Population-based Cohort Study},
	author = {Joung, Kyung-in and Kim, Sukil and Cho, Yoon Hee and Cho, Sung-il},
	year = {2019},
	month = {05},
	date = {2019-05-01},
	journal = {Scientific Reports},
	volume = {9},
	number = {1},
	doi = {10.1038/s41598-019-43066-0},
	url = {http://dx.doi.org/10.1038/s41598-019-43066-0},
	langid = {en}
}

@article{ogino2013,
	title = {Benefits and limits of anticholinergic use in schizophrenia: Focusing on its effect on cognitive function},
	author = {Ogino, Shin and Miyamoto, Seiya and Miyake, Nobumi and Yamaguchi, Noboru},
	year = {2013},
	month = {09},
	date = {2013-09-19},
	journal = {Psychiatry and Clinical Neurosciences},
	pages = {37--49},
	volume = {68},
	number = {1},
	doi = {10.1111/pcn.12088},
	url = {http://dx.doi.org/10.1111/pcn.12088},
	langid = {en}
}

@article{Gallacher2012,
	title = {Benzodiazepine use and risk of dementia: evidence from the Caerphilly Prospective Study (CaPS)},
	author = {Gallacher, John and Elwood, Peter and Pickering, Janet and Bayer, Antony and Fish, Mark and Ben-Shlomo, Yoav},
	year = {2011},
	month = {10},
	date = {2011-10-27},
	journal = {Journal of Epidemiology and Community Health},
	pages = {869--873},
	volume = {66},
	number = {10},
	doi = {10.1136/jech-2011-200314},
	url = {http://dx.doi.org/10.1136/jech-2011-200314},
	langid = {en}
}

@article{barker2004,
	title = {Cognitive Effects of Long-Term Benzodiazepine Use},
	author = {Barker, Melinda J and Greenwood, Kenneth M and Jackson, Martin and Crowe, Simon F},
	year = {2004},
	date = {2004},
	journal = {CNS Drugs},
	pages = {37--48},
	volume = {18},
	number = {1},
	doi = {10.2165/00023210-200418010-00004},
	url = {http://dx.doi.org/10.2165/00023210-200418010-00004},
	langid = {en}
}

@article{baandrup2016,
	title = {Neurocognitive performance, subjective well-being, and psychosocial functioning after benzodiazepine withdrawal in patients with schizophrenia or bipolar disorder: a randomized clinical trial of add-on melatonin versus placebo},
	author = {Baandrup, Lone and Fagerlund, Birgitte and Glenthoj, Birte},
	year = {2016},
	month = {07},
	date = {2016-07-11},
	journal = {European Archives of Psychiatry and Clinical Neuroscience},
	pages = {163--171},
	volume = {267},
	number = {2},
	doi = {10.1007/s00406-016-0711-8},
	url = {http://dx.doi.org/10.1007/s00406-016-0711-8},
	langid = {en}
}

@article{Osler2020,
	title = {Associations of Benzodiazepines, Z-Drugs, and Other Anxiolytics With Subsequent Dementia in Patients With Affective Disorders: A Nationwide Cohort and Nested Case-Control Study},
	author = {Osler, Merete and {Jørgensen}, Martin Balslev},
	year = {2020},
	month = {06},
	date = {2020-06-01},
	journal = {American Journal of Psychiatry},
	pages = {497--505},
	volume = {177},
	number = {6},
	doi = {10.1176/appi.ajp.2019.19030315},
	url = {http://dx.doi.org/10.1176/appi.ajp.2019.19030315},
	langid = {en}
}

@article{Hulkko2017,
	title = {Lifetime use of psychiatric medications and cognition at 43 years of age in schizophrenia in the Northern Finland Birth Cohort 1966},
	author = {Hulkko, A.P. and Murray, G.K. and Moilanen, J. and Haapea, M. and Rannikko, I. and Jones, P.B. and Barnett, J.H. and Huhtaniska, S. and Isohanni, M.K. and Koponen, H. and {Jääskeläinen}, E. and Miettunen, J.},
	year = {2017},
	month = {09},
	date = {2017-09},
	journal = {European Psychiatry},
	pages = {50--58},
	volume = {45},
	doi = {10.1016/j.eurpsy.2017.06.004},
	url = {http://dx.doi.org/10.1016/j.eurpsy.2017.06.004},
	langid = {en}
}

@article{sabia2021,
	title = {Association of sleep duration in middle and old age with incidence of dementia},
	author = {Sabia, {Séverine} and Fayosse, Aurore and Dumurgier, Julien and van Hees, Vincent T. and Paquet, Claire and Sommerlad, Andrew and {Kivimäki}, Mika and Dugravot, Aline and Singh-Manoux, Archana},
	year = {2021},
	month = {04},
	date = {2021-04-20},
	journal = {Nature Communications},
	volume = {12},
	number = {1},
	doi = {10.1038/s41467-021-22354-2},
	url = {http://dx.doi.org/10.1038/s41467-021-22354-2},
	langid = {en}
}

@article{effects1987,
	title = {Effects of amantadine and trihexyphenidyl on memory in elderly normal volunteers},
	year = {1987},
	month = {05},
	date = {1987-05},
	journal = {American Journal of Psychiatry},
	pages = {573--577},
	volume = {144},
	number = {5},
	doi = {10.1176/ajp.144.5.573},
	url = {http://dx.doi.org/10.1176/ajp.144.5.573},
	langid = {en}
}

@article{mora2012,
	title = {Persistence of cognitive impairment and its negative impact on psychosocial functioning in lithium-treated, euthymic bipolar patients: a 6-year follow-up study},
	author = {Mora, E. and Portella, M. J. and Forcada, I. and Vieta, E. and Mur, M.},
	year = {2012},
	month = {08},
	date = {2012-08-31},
	journal = {Psychological Medicine},
	pages = {1187--1196},
	volume = {43},
	number = {6},
	doi = {10.1017/s0033291712001948},
	url = {http://dx.doi.org/10.1017/S0033291712001948},
	langid = {en}
}

@article{paterson2017,
	title = {Lithium and cognition in those with bipolar disorder},
	author = {Paterson, Amelia and Parker, Gordon},
	year = {2017},
	month = {03},
	date = {2017-03},
	journal = {International Clinical Psychopharmacology},
	pages = {57--62},
	volume = {32},
	number = {2},
	doi = {10.1097/yic.0000000000000152},
	url = {http://dx.doi.org/10.1097/YIC.0000000000000152},
	langid = {en}
}

@article{burdick2020,
	title = {The association between lithium use and neurocognitive performance in patients with bipolar disorder},
	author = {Burdick, Katherine E. and Millett, Caitlin E. and Russo, Manuela and Alda, Martin and Alliey-Rodriguez, Ney and Anand, Amit and Balaraman, Yokesh and Berrettini, Wade and Bertram, Holli and Calabrese, Joseph R. and Calkin, Cynthia and Conroy, Carla and Coryell, William and DeModena, Anna and Feeder, Scott and Fisher, Carrie and Frazier, Nicole and Frye, Mark and Gao, Keming and Garnham, Julie and Gershon, Elliot S. and Glazer, Kara and Goes, Fernando S. and Goto, Toyomi and Harrington, Gloria J. and Jakobsen, Petter and Kamali, Masoud and Kelly, Marisa and Leckband, Susan and {Løberg}, Else Marie and Lohoff, Falk W. and Maihofer, Adam X. and McCarthy, Michael J. and McInnis, Melvin and Morken, Gunnar and Nievergelt, Caroline M. and Nurnberger, John and Oedegaard, Ketil J. and Ortiz, Abigail and Ritchey, Megan and Ryan, Kelly and Schinagle, Martha and Schwebel, Candice and Shaw, Martha and Shilling, Paul and Slaney, Claire and Stapp, Emma and Tarwater, Bruce and Zandi, Peter and Kelsoe, John R.},
	year = {2020},
	month = {04},
	date = {2020-04-29},
	journal = {Neuropsychopharmacology},
	pages = {1743--1749},
	volume = {45},
	number = {10},
	doi = {10.1038/s41386-020-0683-2},
	url = {http://dx.doi.org/10.1038/s41386-020-0683-2},
	langid = {en}
}

@article{Forlenza2014,
	title = {Neuroprotective Effects of Lithium: Implications for the Treatment of Alzheimer{\textquoteright}s Disease and Related Neurodegenerative Disorders},
	author = {Forlenza, O. V. and De-Paula, V. J. R. and Diniz, B. S. O.},
	year = {2014},
	month = {05},
	date = {2014-05-06},
	journal = {ACS Chemical Neuroscience},
	pages = {443--450},
	volume = {5},
	number = {6},
	doi = {10.1021/cn5000309},
	url = {http://dx.doi.org/10.1021/cn5000309},
	langid = {en}
}

@article{singh2010,
	title = {Efficacy of antidepressants in treating the negative symptoms of chronic schizophrenia: meta-analysis},
	author = {Singh, Surendra P. and Singh, Vidhi and Kar, Nilamadhab and Chan, Kelvin},
	year = {2010},
	month = {09},
	date = {2010-09},
	journal = {British Journal of Psychiatry},
	pages = {174--179},
	volume = {197},
	number = {3},
	doi = {10.1192/bjp.bp.109.067710},
	url = {http://dx.doi.org/10.1192/bjp.bp.109.067710},
	langid = {en}
}

@article{blumberg2020,
	title = {Procognitive Effects of Antidepressants and Other Therapeutic Agents in Major Depressive Disorder},
	author = {Blumberg, Michelle J. and Vaccarino, Sophie R. and McInerney, Shane J.},
	year = {2020},
	month = {07},
	date = {2020-07-21},
	journal = {The Journal of Clinical Psychiatry},
	volume = {81},
	number = {4},
	doi = {10.4088/jcp.19r13200},
	url = {http://dx.doi.org/10.4088/JCP.19r13200}
}

@article{dawes2012,
	title = {Does Antidepressant Treatment Improve Cognition in Older People with Schizophrenia or Schizoaffective Disorder and Comorbid Subsyndromal Depression?},
	author = {Dawes, Sharron E. and Palmer, Barton W. and Meeks, Thomas and Golshan, Shahrokh and Kasckow, John and Mohamed, Somaia and Zisook, Sidney},
	year = {2012},
	date = {2012},
	journal = {Neuropsychobiology},
	pages = {168--172},
	volume = {65},
	number = {3},
	doi = {10.1159/000331141},
	url = {http://dx.doi.org/10.1159/000331141},
	langid = {en}
}

@article{vernon2014,
	title = {Antidepressants for cognitive impairment in schizophrenia {\textemdash} A systematic review and meta-analysis},
	author = {Vernon, Jeffrey A. and Grudnikoff, Eugene and Seidman, Andrew J. and Frazier, Thomas W. and Vemulapalli, Mani Sandhya and Pareek, Priyanki and Goldberg, Terry E. and Kane, John M. and Correll, Christoph U.},
	year = {2014},
	month = {11},
	date = {2014-11},
	journal = {Schizophrenia Research},
	pages = {385--394},
	volume = {159},
	number = {2-3},
	doi = {10.1016/j.schres.2014.08.015},
	url = {http://dx.doi.org/10.1016/j.schres.2014.08.015},
	langid = {en}
}

@article{terevnikov2015,
	title = {Randomized Controlled Trials of Add-On Antidepressants in Schizophrenia},
	author = {Terevnikov, Viacheslav and Joffe, Grigori and Stenberg, Jan-Henry},
	year = {2015},
	month = {05},
	date = {2015-05-19},
	journal = {International Journal of Neuropsychopharmacology},
	pages = {pyv049},
	volume = {18},
	number = {9},
	doi = {10.1093/ijnp/pyv049},
	url = {http://dx.doi.org/10.1093/ijnp/pyv049},
	langid = {en}
}

@article{Harvey2017,
	title = {Depression in Schizophrenia: Associations With Cognition, Functional Capacity, Everyday Functioning, and Self-Assessment},
	author = {Harvey, Philip D. and Twamley, Elizabeth W. and Pinkham, Amy E. and Depp, Colin A. and Patterson, Thomas L.},
	year = {2016},
	month = {07},
	date = {2016-07-20},
	journal = {Schizophrenia Bulletin},
	pages = {sbw103},
	doi = {10.1093/schbul/sbw103},
	url = {http://dx.doi.org/10.1093/schbul/sbw103},
	langid = {en}
}

@article{tamminga2006,
	title = {The neurobiology of cognition in schizophrenia},
	author = {Tamminga, Carol A.},
	year = {2006},
	date = {2006},
	journal = {The Journal of Clinical Psychiatry},
	volume = {67 Suppl 9},
	note = {PMID: 16965183},
	langid = {eng}
}

@article{sinkeviciute2018,
	title = {Efficacy of different types of cognitive enhancers for patients with schizophrenia: a meta-analysis},
	author = {Sinkeviciute, Igne and Begemann, Marieke and Prikken, Merel and Oranje, Bob and Johnsen, Erik and Lei, Wan U. and Hugdahl, Kenneth and Kroken, Rune A. and Rau, Carina and Jacobs, Jolien D. and Mattaroccia, Silvia and Sommer, Iris E.},
	year = {2018},
	month = {10},
	date = {2018-10-25},
	journal = {npj Schizophrenia},
	volume = {4},
	number = {1},
	doi = {10.1038/s41537-018-0064-6},
	url = {http://dx.doi.org/10.1038/s41537-018-0064-6},
	langid = {en}
}

@article{sawaguchi1994,
	title = {The role of D1-dopamine receptor in working memory: local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task},
	author = {Sawaguchi, T. and Goldman-Rakic, P. S.},
	year = {1994},
	month = {02},
	date = {1994-02-01},
	journal = {Journal of Neurophysiology},
	pages = {515--528},
	volume = {71},
	number = {2},
	doi = {10.1152/jn.1994.71.2.515},
	url = {http://dx.doi.org/10.1152/jn.1994.71.2.515},
	langid = {en}
}

@article{Arnsten2017,
	title = {Novel Dopamine Therapeutics for Cognitive Deficits in Schizophrenia},
	author = {Arnsten, Amy F.T. and Girgis, Ragy R. and Gray, David L. and Mailman, Richard B.},
	year = {2017},
	month = {01},
	date = {2017-01},
	journal = {Biological Psychiatry},
	pages = {67--77},
	volume = {81},
	number = {1},
	doi = {10.1016/j.biopsych.2015.12.028},
	url = {http://dx.doi.org/10.1016/j.biopsych.2015.12.028},
	langid = {en}
}

@article{barch2005,
	title = {Amphetamine improves cognitive function in medicated individuals with schizophrenia and in healthy volunteers},
	author = {Barch, Deanna M. and Carter, Cameron S.},
	year = {2005},
	month = {09},
	date = {2005-09},
	journal = {Schizophrenia Research},
	pages = {43--58},
	volume = {77},
	number = {1},
	doi = {10.1016/j.schres.2004.12.019},
	url = {http://dx.doi.org/10.1016/j.schres.2004.12.019},
	langid = {en}
}

@inbook{barch2010,
	title = {Pharmacological Strategies for Enhancing Cognition in Schizophrenia},
	author = {Barch, Deanna M.},
	year = {2010},
	date = {2010},
	publisher = {Springer Berlin Heidelberg},
	pages = {43--96},
	doi = {10.1007/7854_2010_39},
	url = {http://dx.doi.org/10.1007/7854_2010_39}
}

@article{rosell2014,
	title = {Effects of the D1 Dopamine Receptor Agonist Dihydrexidine (DAR-0100A) on Working Memory in Schizotypal Personality Disorder},
	author = {Rosell, Daniel R and Zaluda, Lauren C and McClure, Margaret M and Perez-Rodriguez, M Mercedes and Strike, K Sloan and Barch, Deanna M and Harvey, Philip D and Girgis, Ragy R and Hazlett, Erin A and Mailman, Richard B and Abi-Dargham, Anissa and Lieberman, Jeffrey A and Siever, Larry J},
	year = {2014},
	month = {07},
	date = {2014-07-30},
	journal = {Neuropsychopharmacology},
	pages = {446--453},
	volume = {40},
	number = {2},
	doi = {10.1038/npp.2014.192},
	url = {http://dx.doi.org/10.1038/npp.2014.192},
	langid = {en}
}

@article{opler2013,
	title = {Pharmacotherapy of cognitive deficits in schizophrenia},
	author = {Opler, Lewis A. and Medalia, Alice and Opler, Mark G. and Stahl, Stephen M.},
	year = {2013},
	month = {11},
	date = {2013-11-08},
	journal = {CNS Spectrums},
	pages = {142--156},
	volume = {19},
	number = {2},
	doi = {10.1017/s1092852913000771},
	url = {http://dx.doi.org/10.1017/S1092852913000771},
	langid = {en}
}

@article{sumiyoshi2001,
	title = {The effect of tandospirone, a serotonin1A agonist, on memory function in schizophrenia},
	author = {Sumiyoshi, Tomiki and Matsui, Mie and Yamashita, Ikiko and Nohara, Shigeru and Kurachi, Masayoshi and Uehara, Takashi and Sumiyoshi, Sawako and Sumiyoshi, Chika and Meltzer, Herbert Y},
	year = {2001},
	month = {05},
	date = {2001-05},
	journal = {Biological Psychiatry},
	pages = {861--868},
	volume = {49},
	number = {10},
	doi = {10.1016/s0006-3223(00)01025-8},
	url = {http://dx.doi.org/10.1016/s0006-3223(00)01025-8},
	langid = {en}
}

@article{sumiyoshi2007,
	title = {Effect of buspirone, a serotonin1A partial agonist, on cognitive function in schizophrenia: A randomized, double-blind, placebo-controlled study},
	author = {Sumiyoshi, Tomiki and Park, Sohee and Jayathilake, Karu and Roy, Ajanta and Ertugrul, Aygun and Meltzer, Herbert Y.},
	year = {2007},
	month = {09},
	date = {2007-09},
	journal = {Schizophrenia Research},
	pages = {158--168},
	volume = {95},
	number = {1-3},
	doi = {10.1016/j.schres.2007.06.008},
	url = {http://dx.doi.org/10.1016/j.schres.2007.06.008},
	langid = {en}
}

@article{akhondzadeh2009,
	title = {Added ondansetron for stable schizophrenia: A double blind, placebo controlled trial},
	author = {Akhondzadeh, Shahin and Mohammadi, Neyousha and Noroozian, Maryam and Karamghadiri, Naregs and Ghoreishi, Aboulfazl and Jamshidi, Amir-Hossein and Forghani, Saeedeh},
	year = {2009},
	month = {02},
	date = {2009-02},
	journal = {Schizophrenia Research},
	pages = {206--212},
	volume = {107},
	number = {2-3},
	doi = {10.1016/j.schres.2008.08.004},
	url = {http://dx.doi.org/10.1016/j.schres.2008.08.004},
	langid = {en}
}

@article{dellechiaie2007,
	title = {Add-on mirtazapine enhances effects on cognition in schizophrenic patients under stabilized treatment with clozapine.},
	author = {Delle Chiaie, Roberto and Salviati, Massimo and Fiorentini, Samantha and Biondi, Massimo},
	year = {2007},
	month = {12},
	date = {2007-12},
	journal = {Experimental and Clinical Psychopharmacology},
	pages = {563--568},
	volume = {15},
	number = {6},
	doi = {10.1037/1064-1297.15.6.563},
	url = {http://dx.doi.org/10.1037/1064-1297.15.6.563},
	langid = {en}
}

@article{berk2009,
	title = {Mirtazapine add-on therapy in the treatment of schizophrenia with atypical antipsychotics: a double-blind, randomised, placebo-controlled clinical trial},
	author = {Berk, Michael and Gama, Clarissa S. and Sundram, Suresh and Hustig, Harry and Koopowitz, Les and {D'Souza}, Russell and Malloy, Hamish and Rowland, Cate and Monkhouse, Alison and Monkhouse, Andrew and Bole, Fiona and Sathiyamoorthy, Sumathy and Piskulic, Danijela and Dodd, Seetal},
	year = {2009},
	month = {04},
	date = {2009-04},
	journal = {Human Psychopharmacology: Clinical and Experimental},
	pages = {233--238},
	volume = {24},
	number = {3},
	doi = {10.1002/hup.1017},
	url = {http://dx.doi.org/10.1002/hup.1017},
	langid = {en}
}

@article{stenberg2009,
	title = {Effects of add-on mirtazapine on neurocognition in schizophrenia: a double-blind, randomized, placebo-controlled study},
	author = {Stenberg, Jan-Henry and Terevnikov, Viatcheslav and Joffe, Marina and Tiihonen, Jari and Tchoukhine, Evgueni and Burkin, Mark and Joffe, Grigori},
	year = {2009},
	month = {11},
	date = {2009-11-27},
	journal = {The International Journal of Neuropsychopharmacology},
	pages = {433},
	volume = {13},
	number = {04},
	doi = {10.1017/s1461145709990897},
	url = {http://dx.doi.org/10.1017/S1461145709990897},
	langid = {en}
}

@article{Perry2018,
	title = {Mirtazapine adjunct for people with schizophrenia},
	author = {Perry, Luke A and Ramson, Dhruvesh and Stricklin, Suzanne},
	editor = {, },
	year = {2018},
	month = {05},
	date = {2018-05-26},
	journal = {Cochrane Database of Systematic Reviews},
	volume = {2018},
	number = {5},
	doi = {10.1002/14651858.cd011943.pub2},
	url = {http://dx.doi.org/10.1002/14651858.CD011943.pub2},
	langid = {en}
}

@article{tsegay2020,
	title = {<p>Serotonin Type 6 and 7 Receptors as a Novel Therapeutic Target for the Treatment of Schizophrenia</p>},
	author = {Tsegay, Etsay Weldekidan and Demise, Desalegn Getnet and Hailu, Nigus Alemu and Gufue, Zenawi Hagos},
	year = {2020},
	month = {10},
	date = {2020-10},
	journal = {Neuropsychiatric Disease and Treatment},
	pages = {2499--2509},
	volume = {Volume 16},
	doi = {10.2147/ndt.s263424},
	url = {http://dx.doi.org/10.2147/NDT.S263424},
	langid = {en}
}

@article{de2015,
	title = {5-HT<sub>6</sub> Receptor Antagonists: Potential Efficacy for the Treatment of Cognitive Impairment in Schizophrenia},
	author = {de Bruin, Natasja and Kruse, Chris},
	year = {2015},
	month = {08},
	date = {2015-08-27},
	journal = {Current Pharmaceutical Design},
	pages = {3739--3759},
	volume = {21},
	number = {26},
	doi = {10.2174/1381612821666150605112105},
	url = {http://dx.doi.org/10.2174/1381612821666150605112105},
	langid = {en}
}

@article{Nygaard2018,
	title = {Targeting Fyn Kinase in Alzheimer{\textquoteright}s Disease},
	author = {Nygaard, Haakon B.},
	year = {2018},
	month = {02},
	date = {2018-02},
	journal = {Biological Psychiatry},
	pages = {369--376},
	volume = {83},
	number = {4},
	doi = {10.1016/j.biopsych.2017.06.004},
	url = {http://dx.doi.org/10.1016/j.biopsych.2017.06.004},
	langid = {en}
}

@article{morozova2013,
	title = {Add-on clinical effects of selective antagonist of 5HT6 receptors AVN-211 (CD-008-0173) in patients with schizophrenia stabilized on antipsychotic treatment: pilot study},
	author = {Morozova, Margarita A. and Lepilkina, Taisiya A. and Rupchev, Georgy E. and Beniashvily, Allan G. and Burminskiy, Denis S. and Potanin, Sergey S. and Bondarenko, Evgeny V. and Kazey, Vasily I. and Lavrovsky, Yan and Ivachtchenko, Alexandre V.},
	year = {2013},
	month = {06},
	date = {2013-06-17},
	journal = {CNS Spectrums},
	pages = {316--323},
	volume = {19},
	number = {4},
	doi = {10.1017/s1092852913000394},
	url = {http://dx.doi.org/10.1017/S1092852913000394},
	langid = {en}
}

@article{capuzzi2021,
	title = {Experimental Serotonergic Agents for the Treatment of Schizophrenia},
	author = {Capuzzi, Enrico and Caldiroli, Alice and Ciscato, Veronica and Russo, Stefania and Buoli, Massimiliano},
	year = {2021},
	month = {02},
	date = {2021-02},
	journal = {Journal of Experimental Pharmacology},
	pages = {49--67},
	volume = {Volume 13},
	doi = {10.2147/jep.s259317},
	url = {http://dx.doi.org/10.2147/JEP.S259317},
	langid = {en}
}

@article{Adler1998,
	title = {Schizophrenia, Sensory Gating, and Nicotinic Receptors},
	author = {Adler, L. E. and Olincy, A. and Waldo, M. and Harris, J. G. and Griffith, J. and Stevens, K. and Flach, K. and Nagamoto, H. and Bickford, P. and Leonard, S. and Freedman, R.},
	year = {1998},
	month = {01},
	date = {1998-01-01},
	journal = {Schizophrenia Bulletin},
	pages = {189--202},
	volume = {24},
	number = {2},
	doi = {10.1093/oxfordjournals.schbul.a033320},
	url = {http://dx.doi.org/10.1093/oxfordjournals.schbul.a033320},
	langid = {en}
}

@article{Caton2020,
	title = {The role of nicotinic cholinergic neurotransmission in delusional thinking},
	author = {Caton, Michael and Ochoa, Enrique L. M. and Barrantes, Francisco J.},
	year = {2020},
	month = {06},
	date = {2020-06-12},
	journal = {npj Schizophrenia},
	volume = {6},
	number = {1},
	doi = {10.1038/s41537-020-0105-9},
	url = {http://dx.doi.org/10.1038/s41537-020-0105-9},
	langid = {en}
}

@article{Quigley2019,
	title = {The relationship between nicotine and psychosis},
	author = {Quigley, Harriet and MacCabe, James H.},
	year = {2019},
	month = {01},
	date = {2019-01},
	journal = {Therapeutic Advances in Psychopharmacology},
	pages = {204512531985996},
	volume = {9},
	doi = {10.1177/2045125319859969},
	url = {http://dx.doi.org/10.1177/2045125319859969},
	langid = {en}
}

@article{Winterer2010,
	title = {Why do patients with schizophrenia smoke?},
	author = {Winterer, Georg},
	year = {2010},
	month = {03},
	date = {2010-03},
	journal = {Current Opinion in Psychiatry},
	pages = {112--119},
	volume = {23},
	number = {2},
	doi = {10.1097/yco.0b013e3283366643},
	url = {http://dx.doi.org/10.1097/YCO.0b013e3283366643},
	langid = {en}
}

@article{Zammit2003,
	title = {Investigating the Association Between Cigarette Smoking and Schizophrenia in a Cohort Study},
	author = {Zammit, Stanley and Allebeck, Peter and Dalman, Christina and Lundberg, Ingvar and Hemmingsson, Tomas and Lewis, Glyn},
	year = {2003},
	month = {12},
	date = {2003-12},
	journal = {American Journal of Psychiatry},
	pages = {2216--2221},
	volume = {160},
	number = {12},
	doi = {10.1176/appi.ajp.160.12.2216},
	url = {http://dx.doi.org/10.1176/appi.ajp.160.12.2216},
	langid = {en}
}

@article{kumari2005,
	title = {Nicotine use in schizophrenia: The self medication hypotheses},
	author = {Kumari, Veena and Postma, Peggy},
	year = {2005},
	month = {01},
	date = {2005-01},
	journal = {Neuroscience & Biobehavioral Reviews},
	pages = {1021--1034},
	volume = {29},
	number = {6},
	doi = {10.1016/j.neubiorev.2005.02.006},
	url = {http://dx.doi.org/10.1016/j.neubiorev.2005.02.006},
	langid = {en}
}

@article{khantzian1997,
	title = {The Self-Medication Hypothesis of Substance Use Disorders: A Reconsideration and Recent Applications},
	author = {Khantzian, Edward J.},
	year = {1997},
	month = {01},
	date = {1997-01},
	journal = {Harvard Review of Psychiatry},
	pages = {231--244},
	volume = {4},
	number = {5},
	doi = {10.3109/10673229709030550},
	url = {http://dx.doi.org/10.3109/10673229709030550},
	langid = {en}
}

@article{barr2007,
	title = {The Effects of Transdermal Nicotine on Cognition in Nonsmokers with Schizophrenia and Nonpsychiatric Controls},
	author = {Barr, Ruth S and Culhane, Melissa A and Jubelt, Lindsay E and Mufti, Rana S and Dyer, Michael A and Weiss, Anthony P and Deckersbach, Thilo and Kelly, John F and Freudenreich, Oliver and Goff, Donald C and Evins, A Eden},
	year = {2007},
	month = {04},
	date = {2007-04-18},
	journal = {Neuropsychopharmacology},
	pages = {480--490},
	volume = {33},
	number = {3},
	doi = {10.1038/sj.npp.1301423},
	url = {http://dx.doi.org/10.1038/sj.npp.1301423},
	langid = {en}
}

@article{Campos2016,
	title = {Smoking and Cognition},
	author = {Campos, Marcela Waisman and Serebrisky, Debora and Castaldelli-Maia, Joao Mauricio},
	year = {2017},
	month = {05},
	date = {2017-05-17},
	journal = {Current Drug Abuse Reviews},
	pages = {76--79},
	volume = {9},
	number = {2},
	doi = {10.2174/1874473709666160803101633},
	url = {http://dx.doi.org/10.2174/1874473709666160803101633},
	langid = {en}
}

@article{olincy2007,
	title = {Treating schizophrenia symptoms with an α7 nicotinic agonist, from mice to men},
	author = {Olincy, Ann and Stevens, Karen E.},
	year = {2007},
	month = {10},
	date = {2007-10},
	journal = {Biochemical Pharmacology},
	pages = {1192--1201},
	volume = {74},
	number = {8},
	doi = {10.1016/j.bcp.2007.07.015},
	url = {http://dx.doi.org/10.1016/j.bcp.2007.07.015},
	langid = {en}
}

@article{kem2006,
	title = {The Nemertine Toxin Anabaseine and Its Derivative DMXBA (GTS-21): Chemical and Pharmacological Properties},
	author = {Kem, William and Soti, Ferenc and Wildeboer, Kristin and LeFrancois, Susan and MacDougall, Kelly and Wei, Dong-Qing and Chou, Kuo-Chen and Arias, Hugo},
	year = {2006},
	month = {04},
	date = {2006-04-06},
	journal = {Marine Drugs},
	pages = {255--273},
	volume = {4},
	number = {3},
	doi = {10.3390/md403255},
	url = {http://dx.doi.org/10.3390/md403255},
	langid = {en}
}

@article{freedman2008,
	title = {Initial Phase 2 Trial of a Nicotinic Agonist in Schizophrenia},
	author = {Freedman, Robert and Olincy, Ann and Buchanan, Robert W. and Harris, Josette G. and Gold, James M. and Johnson, Lynn and Allensworth, Diana and Guzman-Bonilla, Alejandrina and Clement, Bettye and Ball, M. Patricia and Kutnick, Jay and Pender, Vicki and Martin, Laura F. and Stevens, Karen E. and Wagner, Brandie D. and Zerbe, Gary O. and Soti, Ferenc and Kem, William R.},
	year = {2008},
	month = {08},
	date = {2008-08},
	journal = {American Journal of Psychiatry},
	pages = {1040--1047},
	volume = {165},
	number = {8},
	doi = {10.1176/appi.ajp.2008.07071135},
	url = {http://dx.doi.org/10.1176/appi.ajp.2008.07071135},
	langid = {en}
}

@article{kem2017,
	title = {Pharmacokinetic Limitations on Effects of an Alpha7-Nicotinic Receptor Agonist in Schizophrenia: Randomized Trial with an Extended-Release Formulation},
	author = {Kem, William R and Olincy, Ann and Johnson, Lynn and Harris, Josette and Wagner, Brandie D and Buchanan, Robert W and Christians, Uwe and Freedman, Robert},
	year = {2017},
	month = {08},
	date = {2017-08-21},
	journal = {Neuropsychopharmacology},
	pages = {583--589},
	volume = {43},
	number = {3},
	doi = {10.1038/npp.2017.182},
	url = {http://dx.doi.org/10.1038/npp.2017.182},
	langid = {en}
}

@article{poddar2018,
	title = {Tropisetron enhances recognition memory in rats chronically treated with risperidone or quetiapine},
	author = {Poddar, Indrani and Callahan, Patrick M. and Hernandez, Caterina M. and Yang, Xiangkun and Bartlett, Michael G. and Terry, Alvin V.},
	year = {2018},
	month = {05},
	date = {2018-05},
	journal = {Biochemical Pharmacology},
	pages = {180--187},
	volume = {151},
	doi = {10.1016/j.bcp.2017.11.017},
	url = {http://dx.doi.org/10.1016/j.bcp.2017.11.017},
	langid = {en}
}

@article{zhang2012,
	title = {Short-Term Tropisetron Treatment and Cognitive and P50 Auditory Gating Deficits in Schizophrenia},
	author = {Zhang, Xiang Yang and Liu, Lei and Liu, Shaowen and Hong, Xiaohong and Chen, Da Chun and Xiu, Mei Hong and De Yang, Fu and Zhang, Zhijun and Zhang, Xiangrong and Kosten, Therese A. and Kosten, Thomas R.},
	year = {2012},
	month = {09},
	date = {2012-09},
	journal = {American Journal of Psychiatry},
	pages = {974--981},
	volume = {169},
	number = {9},
	doi = {10.1176/appi.ajp.2012.11081289},
	url = {http://dx.doi.org/10.1176/appi.ajp.2012.11081289},
	langid = {en}
}

@article{xia2020,
	title = {One-day tropisetron treatment improves cognitive deficits and P50 inhibition deficits in schizophrenia},
	author = {Xia, Luyao and Liu, Lei and Hong, Xiaohong and Wang, Dongmei and Wei, Gaoxia and Wang, Jiesi and Zhou, Huixia and Xu, Hang and Tian, Yang and Dai, Qilong and Wu, Hanjing E. and Chang, Catherine and Wang, Li and Kosten, Thomas R. and Zhang, Xiang Yang},
	year = {2020},
	month = {04},
	date = {2020-04-29},
	journal = {Neuropsychopharmacology},
	pages = {1362--1368},
	volume = {45},
	number = {8},
	doi = {10.1038/s41386-020-0685-0},
	url = {http://dx.doi.org/10.1038/s41386-020-0685-0},
	langid = {en}
}

@article{tregellas2018,
	title = {Alpha7 Nicotinic Receptors as Therapeutic Targets in Schizophrenia},
	author = {Tregellas, Jason R and Wylie, Korey P},
	year = {2018},
	month = {08},
	date = {2018-08-23},
	journal = {Nicotine & Tobacco Research},
	pages = {349--356},
	volume = {21},
	number = {3},
	doi = {10.1093/ntr/nty034},
	url = {http://dx.doi.org/10.1093/ntr/nty034},
	langid = {en}
}

@article{koola2020,
	title = {Meta-analysis of randomized controlled trials of galantamine in schizophrenia: significant cognitive enhancement},
	author = {Koola, Maju Mathew and Looney, Stephen W. and Hong, Houlin and Pillai, Anilkumar and Hou, Wei},
	year = {2020},
	month = {09},
	date = {2020-09},
	journal = {Psychiatry Research},
	pages = {113285},
	volume = {291},
	doi = {10.1016/j.psychres.2020.113285},
	url = {http://dx.doi.org/10.1016/j.psychres.2020.113285},
	langid = {en}
}

@article{Gee2017,
	title = {First in human trial of a type I positive allosteric modulator of alpha7-nicotinic acetylcholine receptors: Pharmacokinetics, safety, and evidence for neurocognitive effect of AVL-3288},
	author = {Gee, Kelvin W and Olincy, Ann and Kanner, Richard and Johnson, Lynn and Hogenkamp, Derk and Harris, Josette and Tran, Minhtam and Edmonds, Stephen A and Sauer, William and Yoshimura, Ryan and Johnstone, Timothy and Freedman, Robert},
	year = {2017},
	month = {02},
	date = {2017-02-15},
	journal = {Journal of Psychopharmacology},
	pages = {434--441},
	volume = {31},
	number = {4},
	doi = {10.1177/0269881117691590},
	url = {http://dx.doi.org/10.1177/0269881117691590},
	langid = {en}
}

@article{friedman2002,
	title = {A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia},
	author = {Friedman, Joseph I and Adler, David N and Howanitz, Evelyn and Harvey, Philip D and Brenner, Grant and Temporini, Humberto and White, Leonard and Parrella, Michael},
	year = {2002},
	month = {03},
	date = {2002-03},
	journal = {Biological Psychiatry},
	pages = {349--357},
	volume = {51},
	number = {5},
	doi = {10.1016/s0006-3223(01)01342-7},
	url = {http://dx.doi.org/10.1016/s0006-3223(01)01342-7},
	langid = {en}
}

@article{lee2006,
	title = {A 12-week, double-blind, placebo-controlled trial of donepezil as an adjunct                 to haloperidol for treating cognitive impairments in patients with chronic schizophrenia},
	author = {Lee, Bong-Ju and Lee, Jung-Goo and Kim, Young-Hoon},
	year = {2006},
	month = {08},
	date = {2006-08-04},
	journal = {Journal of Psychopharmacology},
	pages = {421--427},
	volume = {21},
	number = {4},
	doi = {10.1177/0269881106070996},
	url = {http://dx.doi.org/10.1177/0269881106070996},
	langid = {en}
}

@article{thakurathi2012,
	title = {Assessing the prospect of donepezil in improving cognitive impairment in patients with schizophrenia},
	author = {Thakurathi, Neelam and Vincenzi, Brenda and Henderson, David C},
	year = {2012},
	month = {12},
	date = {2012-12-09},
	journal = {Expert Opinion on Investigational Drugs},
	pages = {259--265},
	volume = {22},
	number = {2},
	doi = {10.1517/13543784.2013.750650},
	url = {http://dx.doi.org/10.1517/13543784.2013.750650},
	langid = {en}
}

@article{schubert2006,
	title = {Galantamine Improves Cognition in Schizophrenic Patients Stabilized on Risperidone},
	author = {Schubert, Max H. and Young, Keith A. and Hicks, Paul B.},
	year = {2006},
	month = {09},
	date = {2006-09},
	journal = {Biological Psychiatry},
	pages = {530--533},
	volume = {60},
	number = {6},
	doi = {10.1016/j.biopsych.2006.04.006},
	url = {http://dx.doi.org/10.1016/j.biopsych.2006.04.006},
	langid = {en}
}

@article{Javitt1994,
	title = {Amelioration of negative symptoms in schizophrenia by glycine},
	year = {1994},
	month = {08},
	date = {1994-08},
	journal = {American Journal of Psychiatry},
	pages = {1234--1236},
	volume = {151},
	number = {8},
	doi = {10.1176/ajp.151.8.1234},
	url = {http://dx.doi.org/10.1176/ajp.151.8.1234},
	langid = {en}
}

@article{herescolevy1996,
	title = {Glycinergic augmentation of NMDA receptor-mediated neurotransmission in the treatment of schizophrenia},
	author = {Heresco-Levy, U. and Silipo, G. and Javitt, D. C.},
	year = {1996},
	date = {1996},
	journal = {Psychopharmacology Bulletin},
	pages = {731--740},
	volume = {32},
	number = {4},
	note = {PMID: 8993096},
	langid = {eng}
}

@article{Goff1995,
	title = {Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia},
	year = {1995},
	month = {08},
	date = {1995-08},
	journal = {American Journal of Psychiatry},
	pages = {1213--1215},
	volume = {152},
	number = {8},
	doi = {10.1176/ajp.152.8.1213},
	url = {http://dx.doi.org/10.1176/ajp.152.8.1213},
	langid = {en}
}

@article{Goff2008,
	title = {Once-weekly d-cycloserine effects on negative symptoms and cognition in schizophrenia: An exploratory study},
	author = {GOFF, D and CATHER, C and GOTTLIEB, J and EVINS, A and WALSH, J and RAEKE, L and OTTO, M and SCHOENFELD, D and GREEN, M},
	year = {2008},
	month = {12},
	date = {2008-12},
	journal = {Schizophrenia Research},
	pages = {320--327},
	volume = {106},
	number = {2-3},
	doi = {10.1016/j.schres.2008.08.012},
	url = {http://dx.doi.org/10.1016/j.schres.2008.08.012},
	langid = {en}
}

@article{Tsai2010,
	title = {Strategies to Enhance N-Methyl-D-Aspartate Receptor-Mediated Neurotransmission in Schizophrenia, a Critical Review and Meta-Analysis},
	author = {Tsai, Guochuan and Lin, Pao-Yen},
	year = {2010},
	month = {02},
	date = {2010-02-01},
	journal = {Current Pharmaceutical Design},
	pages = {522--537},
	volume = {16},
	number = {5},
	doi = {10.2174/138161210790361452},
	url = {http://dx.doi.org/10.2174/138161210790361452},
	langid = {en}
}

@article{Goff2017,
	title = {D-cycloserine in Schizophrenia: New Strategies for Improving Clinical Outcomes by Enhancing Plasticity},
	author = {Goff, Donald C.},
	year = {2017},
	month = {01},
	date = {2017-01},
	journal = {Current Neuropharmacology},
	pages = {21--34},
	volume = {15},
	number = {1},
	doi = {10.2174/1570159x14666160225154812},
	url = {http://dx.doi.org/10.2174/1570159x14666160225154812},
	langid = {en}
}

@article{wolosker2020,
	title = {d-Serine as the gatekeeper of NMDA receptor activity: implications for the pharmacologic management of anxiety disorders},
	author = {Wolosker, Herman and Balu, Darrick T.},
	year = {2020},
	month = {06},
	date = {2020-06-09},
	journal = {Translational Psychiatry},
	volume = {10},
	number = {1},
	doi = {10.1038/s41398-020-00870-x},
	url = {http://dx.doi.org/10.1038/s41398-020-00870-x},
	langid = {en}
}

@article{Contreras1990,
	title = {D-serine antagonized phencyclidine- and MK-801-induced stereotyped behavior and ataxia},
	author = {Contreras, Patricia C.},
	year = {1990},
	month = {03},
	date = {1990-03},
	journal = {Neuropharmacology},
	pages = {291--293},
	volume = {29},
	number = {3},
	doi = {10.1016/0028-3908(90)90015-j},
	url = {http://dx.doi.org/10.1016/0028-3908(90)90015-j},
	langid = {en}
}

@article{tsai1998,
	title = {D-serine added to antipsychotics for the treatment of schizophrenia},
	author = {Tsai, Guochuan and Yang, Pinchen and Chung, Li-Chen and Lange, Nicholas and Coyle, Joseph T.},
	year = {1998},
	month = {12},
	date = {1998-12},
	journal = {Biological Psychiatry},
	pages = {1081--1089},
	volume = {44},
	number = {11},
	doi = {10.1016/s0006-3223(98)00279-0},
	url = {http://dx.doi.org/10.1016/S0006-3223(98)00279-0},
	langid = {en}
}

@article{kantrowitz2010,
	title = {High dose D-serine in the treatment of schizophrenia},
	author = {Kantrowitz, Joshua T. and Malhotra, Anil K. and Cornblatt, Barbara and Silipo, Gail and Balla, Andrea and Suckow, Raymond F. and {D'Souza}, Cyril and Saksa, John and Woods, Scott W. and Javitt, Daniel C.},
	year = {2010},
	month = {08},
	date = {2010-08},
	journal = {Schizophrenia Research},
	pages = {125--130},
	volume = {121},
	number = {1-3},
	doi = {10.1016/j.schres.2010.05.012},
	url = {http://dx.doi.org/10.1016/j.schres.2010.05.012},
	langid = {en}
}

@article{kantrowitz2018,
	title = {Improvement in mismatch negativity generation during d-serine treatment in schizophrenia: Correlation with symptoms},
	author = {Kantrowitz, Joshua T. and Epstein, Michael L. and Lee, Migyung and Lehrfeld, Nayla and Nolan, Karen A and Shope, Constance and Petkova, Eva and Silipo, Gail and Javitt, Daniel C.},
	year = {2018},
	month = {01},
	date = {2018-01},
	journal = {Schizophrenia Research},
	pages = {70--79},
	volume = {191},
	doi = {10.1016/j.schres.2017.02.027},
	url = {http://dx.doi.org/10.1016/j.schres.2017.02.027},
	langid = {en}
}

@article{MacKay2019,
	title = {D-Serine: Potential Therapeutic Agent and/or Biomarker in Schizophrenia and Depression?},
	author = {MacKay, Mary-Anne B. and Kravtsenyuk, Maryana and Thomas, Rejish and Mitchell, Nicholas D. and Dursun, Serdar M. and Baker, Glen B.},
	year = {2019},
	month = {02},
	date = {2019-02-06},
	journal = {Frontiers in Psychiatry},
	volume = {10},
	doi = {10.3389/fpsyt.2019.00025},
	url = {http://dx.doi.org/10.3389/fpsyt.2019.00025}
}

@article{Buchanan2007,
	title = {The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): The Efficacy of Glutamatergic Agents for Negative Symptoms and Cognitive Impairments},
	author = {Buchanan, Robert W. and Javitt, Daniel C. and Marder, Stephen R. and Schooler, Nina R. and Gold, James M. and McMahon, Robert P. and Heresco-Levy, Uriel and Carpenter, William T.},
	year = {2007},
	month = {10},
	date = {2007-10},
	journal = {American Journal of Psychiatry},
	pages = {1593--1602},
	volume = {164},
	number = {10},
	doi = {10.1176/appi.ajp.2007.06081358},
	url = {http://dx.doi.org/10.1176/appi.ajp.2007.06081358},
	langid = {en}
}

@article{singer2015,
	title = {Inhibition of glycine transporter 1: The yellow brick road to new schizophrenia therapy?},
	author = {Singer, Philipp and Dubroqua, Sylvain and Yee, Benjamin},
	year = {2015},
	month = {08},
	date = {2015-08-27},
	journal = {Current Pharmaceutical Design},
	pages = {3771--3787},
	volume = {21},
	number = {26},
	doi = {10.2174/1381612821666150724100952},
	url = {http://dx.doi.org/10.2174/1381612821666150724100952},
	langid = {en}
}

@article{meador-woodruff2000,
	title = {Glutamate receptor expression in schizophrenic brain},
	author = {Meador-Woodruff, J},
	year = {2000},
	month = {03},
	date = {2000-03},
	journal = {Brain Research Reviews},
	pages = {288--294},
	volume = {31},
	number = {2-3},
	doi = {10.1016/s0165-0173(99)00044-2},
	url = {http://dx.doi.org/10.1016/s0165-0173(99)00044-2}
}

@article{goff2001,
	title = {A Placebo-Controlled Pilot Study of the Ampakine CX516 Added to Clozapine in Schizophrenia},
	author = {Goff, Donald C. and Leahy, Leslie and Berman, Ileana and Posever, Thomas and Herz, Lawrence and Leon, Andrew C. and Johnson, Steven A. and Lynch, Gary},
	year = {2001},
	month = {10},
	date = {2001-10},
	journal = {Journal of Clinical Psychopharmacology},
	pages = {484--487},
	volume = {21},
	number = {5},
	doi = {10.1097/00004714-200110000-00005},
	url = {http://dx.doi.org/10.1097/00004714-200110000-00005},
	langid = {en}
}

@article{goff2007,
	title = {A Placebo-Controlled Add-On Trial of the Ampakine, CX516, for Cognitive Deficits in Schizophrenia},
	author = {Goff, Donald C and Lamberti, J Steven and Leon, Andrew C and Green, Michael F and Miller, Alexander L and Patel, Jayendra and Manschreck, Theo and Freudenreich, Oliver and Johnson, Steven A},
	year = {2007},
	month = {05},
	date = {2007-05-09},
	journal = {Neuropsychopharmacology},
	pages = {465--472},
	volume = {33},
	number = {3},
	doi = {10.1038/sj.npp.1301444},
	url = {http://dx.doi.org/10.1038/sj.npp.1301444},
	langid = {en}
}

@article{ward2015,
	title = {AMPA receptor-positive allosteric modulators for the treatment of schizophrenia: an overview of recent patent applications},
	author = {Ward, Simon E and Pennicott, Lewis E and Beswick, Paul},
	year = {2015},
	month = {03},
	date = {2015-03},
	journal = {Future Medicinal Chemistry},
	pages = {473--491},
	volume = {7},
	number = {4},
	doi = {10.4155/fmc.15.4},
	url = {http://dx.doi.org/10.4155/fmc.15.4},
	langid = {en}
}

@article{menzies2007,
	title = {Effects of γ-Aminobutyric Acid{\textendash}Modulating Drugs on Working Memory and Brain Function in Patients With Schizophrenia},
	author = {Menzies, Lara and Ooi, Cinly and Kamath, Shri and Suckling, John and McKenna, Peter and Fletcher, Paul and Bullmore, Ed and Stephenson, Caroline},
	year = {2007},
	month = {02},
	date = {2007-02-01},
	journal = {Archives of General Psychiatry},
	pages = {156},
	volume = {64},
	number = {2},
	doi = {10.1001/archpsyc.64.2.156},
	url = {http://dx.doi.org/10.1001/archpsyc.64.2.156},
	langid = {en}
}

@article{lewis2008,
	title = {Subunit-Selective Modulation of GABA Type A Receptor Neurotransmission and Cognition in Schizophrenia},
	author = {Lewis, David A. and Cho, Raymond Y. and Carter, Cameron S. and Eklund, Kevin and Forster, Sarah and Kelly, Mary Ann and Montrose, Debra},
	year = {2008},
	month = {12},
	date = {2008-12},
	journal = {American Journal of Psychiatry},
	pages = {1585--1593},
	volume = {165},
	number = {12},
	doi = {10.1176/appi.ajp.2008.08030395},
	url = {http://dx.doi.org/10.1176/appi.ajp.2008.08030395},
	langid = {en}
}

@article{buchanan2011,
	title = {A Randomized Clinical Trial of MK-0777 for the Treatment of Cognitive Impairments in People with Schizophrenia},
	author = {Buchanan, Robert W. and Keefe, Richard S.E. and Lieberman, Jeffrey A. and Barch, Deanna M. and Csernansky, John G. and Goff, Donald C. and Gold, James M. and Green, Michael F. and Jarskog, L. Fredrik and Javitt, Daniel C. and Kimhy, David and Kraus, Michael S. and McEvoy, Joseph P. and Mesholam-Gately, Raquelle I. and Seidman, Larry J. and Ball, M. Patricia and McMahon, Robert P. and Kern, Robert S. and Robinson, James and Marder, Stephen R.},
	year = {2011},
	month = {03},
	date = {2011-03},
	journal = {Biological Psychiatry},
	pages = {442--449},
	volume = {69},
	number = {5},
	doi = {10.1016/j.biopsych.2010.09.052},
	url = {http://dx.doi.org/10.1016/j.biopsych.2010.09.052},
	langid = {en}
}

@article{Fan2018,
	title = {Quercetin Reduces Cortical GABAergic Transmission and Alleviates MK-801-Induced Hyperactivity},
	author = {Fan, Hui-Ran and Du, Wei-Feng and Zhu, Tao and Wu, Yan-Jiao and Liu, Yan-Mei and Wang, Qi and Wang, Qin and Gu, Xue and Shan, Xingyue and Deng, Shining and Zhu, Tailin and Xu, Tian-Le and Ge, Wei-Hong and Li, Wei-Guang and Li, Fei},
	year = {2018},
	month = {08},
	date = {2018-08},
	journal = {EBioMedicine},
	pages = {201--213},
	volume = {34},
	doi = {10.1016/j.ebiom.2018.07.031},
	url = {http://dx.doi.org/10.1016/j.ebiom.2018.07.031},
	langid = {en}
}

@article{chen2018,
	title = {Gender differences in the relationships among neurosteroid serum levels, cognitive function, and quality of life},
	author = {Chen, Chien-Yu and Wu, Chih-Ching and Huang, Yu-Chi and Hung, Chi-Fa and Wang, Liang-Jen},
	year = {2018},
	month = {09},
	date = {2018-09},
	journal = {Neuropsychiatric Disease and Treatment},
	pages = {2389--2399},
	volume = {Volume 14},
	doi = {10.2147/ndt.s176047},
	url = {http://dx.doi.org/10.2147/NDT.S176047},
	langid = {en}
}

@article{maninger2009,
	title = {Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS)},
	author = {Maninger, Nicole and Wolkowitz, Owen M. and Reus, Victor I. and Epel, Elissa S. and Mellon, Synthia H.},
	year = {2009},
	month = {01},
	date = {2009-01},
	journal = {Frontiers in Neuroendocrinology},
	pages = {65--91},
	volume = {30},
	number = {1},
	doi = {10.1016/j.yfrne.2008.11.002},
	url = {http://dx.doi.org/10.1016/j.yfrne.2008.11.002},
	langid = {en}
}

@article{ritsner2006,
	title = {Improvement of Sustained Attention and Visual and Movement Skills, but Not Clinical Symptoms, After Dehydroepiandrosterone Augmentation in Schizophrenia},
	author = {Ritsner, Michael S. and Gibel, Anatoly and Ratner, Yael and Tsinovoy, German and Strous, Rael D.},
	year = {2006},
	month = {10},
	date = {2006-10},
	journal = {Journal of Clinical Psychopharmacology},
	pages = {495--499},
	volume = {26},
	number = {5},
	doi = {10.1097/01.jcp.0000237942.50270.35},
	url = {http://dx.doi.org/10.1097/01.jcp.0000237942.50270.35},
	langid = {en}
}

@article{strous2003,
	title = {Dehydroepiandrosterone Augmentation in the Management of Negative, Depressive, and Anxiety Symptoms in Schizophrenia},
	author = {Strous, Rael D. and Maayan, Rachel and Lapidus, Raya and Stryjer, Rafael and Lustig, Michal and Kotler, Moshe and Weizman, Abraham},
	year = {2003},
	month = {02},
	date = {2003-02-01},
	journal = {Archives of General Psychiatry},
	pages = {133},
	volume = {60},
	number = {2},
	doi = {10.1001/archpsyc.60.2.133},
	url = {http://dx.doi.org/10.1001/archpsyc.60.2.133},
	langid = {en}
}

@article{ritsner2010,
	title = {Neurocognitive deficits in schizophrenia are associated with alterations in blood levels of neurosteroids: A multiple regression analysis of findings from a double-blind, randomized, placebo-controlled, crossover trial with DHEA},
	author = {Ritsner, Michael S. and Strous, Rael D.},
	year = {2010},
	month = {01},
	date = {2010-01},
	journal = {Journal of Psychiatric Research},
	pages = {75--80},
	volume = {44},
	number = {2},
	doi = {10.1016/j.jpsychires.2009.07.002},
	url = {http://dx.doi.org/10.1016/j.jpsychires.2009.07.002},
	langid = {en}
}

@article{ritsner2010a,
	title = {Pregnenolone and Dehydroepiandrosterone as an Adjunctive Treatment in Schizophrenia and Schizoaffective Disorder},
	author = {Ritsner, Michael S. and Gibel, Anatoly and Shleifer, Tatyana and Boguslavsky, Igor and Zayed, Ahmad and Maayan, Rachel and Weizman, Abraham and Lerner, Vladimir},
	year = {2010},
	month = {06},
	date = {2010-06-15},
	journal = {The Journal of Clinical Psychiatry},
	pages = {1351--1362},
	volume = {71},
	number = {10},
	doi = {10.4088/jcp.09m05031yel},
	url = {http://dx.doi.org/10.4088/JCP.09m05031yel}
}

@article{marx2014,
	title = {Proof-of-concept randomized controlled trial of pregnenolone in schizophrenia},
	author = {Marx, Christine E. and Lee, Jimmy and Subramaniam, Mythily and Rapisarda, Attilio and Bautista, Dianne C. T. and Chan, Edwin and Kilts, Jason D. and Buchanan, Robert W. and Wai, Eu Pui and Verma, Swapna and Sim, Kang and Hariram, Jayaraman and Jacob, Rajesh and Keefe, Richard S. E. and Chong, Siow Ann},
	year = {2014},
	month = {07},
	date = {2014-07-17},
	journal = {Psychopharmacology},
	pages = {3647--3662},
	volume = {231},
	number = {17},
	doi = {10.1007/s00213-014-3673-4},
	url = {http://dx.doi.org/10.1007/s00213-014-3673-4},
	langid = {en}
}

@article{Garrido-Mesa2013,
	title = {Minocycline: far beyond an antibiotic},
	author = {Garrido-Mesa, N and Zarzuelo, A and {Gálvez}, J},
	year = {2013},
	month = {04},
	date = {2013-04-25},
	journal = {British Journal of Pharmacology},
	pages = {337--352},
	volume = {169},
	number = {2},
	doi = {10.1111/bph.12139},
	url = {http://dx.doi.org/10.1111/bph.12139},
	langid = {en}
}

@article{Solmi2017,
	title = {Systematic review and meta-analysis of the efficacy and safety of minocycline in schizophrenia},
	author = {Solmi, Marco and Veronese, Nicola and Thapa, Nita and Facchini, Silvia and Stubbs, Brendon and Fornaro, Michele and Carvalho, {André F.} and Correll, Christoph U.},
	year = {2017},
	month = {02},
	date = {2017-02-09},
	journal = {CNS Spectrums},
	pages = {415--426},
	volume = {22},
	number = {5},
	doi = {10.1017/s1092852916000638},
	url = {http://dx.doi.org/10.1017/S1092852916000638},
	langid = {en}
}

@article{Chaves2021,
	title = {Tetracyclines, a promise for neuropsychiatric disorders: from adjunctive therapy to the discovery of new targets for rational drug design in psychiatry},
	author = {Chaves Filho, {Adriano José Maia} and Mottin, Melina and Soares, Michele Verde-Ramo and {Jucá}, Paloma Marinho and Andrade, Carolina Horta and Macedo, Danielle S.},
	year = {2021},
	month = {02},
	date = {2021-02-15},
	journal = {Behavioural Pharmacology},
	pages = {123--141},
	volume = {32},
	number = {2&3},
	doi = {10.1097/fbp.0000000000000585},
	url = {http://dx.doi.org/10.1097/FBP.0000000000000585},
	langid = {en}
}
